Robust equity market performance and an active IPO pipeline are supporting trader sentiment on 2026 listings ahead of the December 31, 2026 resolution. Through late September, 122 IPOs have priced year-to-date, generating an average 8.5% return from issue price amid a Nasdaq Composite advance of 35%. Multiple sizable deals are slated to price imminently, including Oura’s $2.1 billion offering, Accelevation Holdings’ $660 million transaction, and ADARx Pharmaceuticals’ $350 million raise, while others such as Bamboo Insurance have been postponed. Favorable conditions reflect sustained risk appetite, with institutional demand for growth-oriented issuers in AI infrastructure, biotech, and consumer hardware. Key near-term catalysts include additional September and October pricings plus any confidential filings that could accelerate timelines for high-profile names.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$7,377,936 Vol.
Dec 31, 2026
Anthropic
76%
Discord
11%
Deel
5%
Perplexity
5%
Epic Games
4%
ByteDance
4%
Databricks
4%
Anduril
3%
Anduril Industries
3%
Fannie Mae
3%
Ripple Labs
3%
Freddie Mac
3%
Rippling
3%
OpenAI
3%
Celonis
3%
Ramp
3%
Ledger
3%
Remote
3%
Stripe
3%
Vanta
2%
Revolut
2%
Anysphere (Cursor)
2%
Mistral AI
2%
Canva
2%
Waymo
2%
Applied Intuition
2%
WHOOP
2%
Brex
1%
Glean
1%
$7,377,936 Vol.
Anthropic
$582,539 Vol.
76%
Discord
$482,182 Vol.
11%
Deel
$134,954 Vol.
5%
Perplexity
$33 Vol.
5%
Epic Games
$94,819 Vol.
4%
ByteDance
$31,728 Vol.
4%
Databricks
$494,035 Vol.
4%
Anduril
$363,250 Vol.
3%
Anduril Industries
$49,174 Vol.
3%
Fannie Mae
$179,642 Vol.
3%
Ripple Labs
$157,864 Vol.
3%
Freddie Mac
$246,021 Vol.
3%
Rippling
$121,693 Vol.
3%
OpenAI
$564,717 Vol.
3%
Celonis
$210,980 Vol.
3%
Ramp
$156,367 Vol.
3%
Ledger
$514,363 Vol.
3%
Remote
$56,466 Vol.
3%
Stripe
$268,813 Vol.
3%
Vanta
$149,076 Vol.
2%
Revolut
$61,211 Vol.
2%
Anysphere (Cursor)
$104,951 Vol.
2%
Mistral AI
$166,570 Vol.
2%
Canva
$39,143 Vol.
2%
Waymo
$54,593 Vol.
2%
Applied Intuition
$206,740 Vol.
2%
WHOOP
$4,371 Vol.
2%
Brex
$222,053 Vol.
1%
Glean
$52,345 Vol.
1%
This market will resolve to "Yes" if the listed company completes an Initial Public Offering (IPO) by December 31, 2026, 11:59 PM ET, as confirmed by official company announcements or credible news sources. The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange.
If the listed company merges with another entity, is acquired, or ceases to exist before the market resolves, the market will also resolve to "No".
This market will resolve early if the listed company completes an IPO by December 31, 2026, 11:59 PM ET.
The resolution source for this market is a consensus of credible reporting.This market will resolve to "Yes" if the listed company completes an Initial Public Offering (IPO) by December 31, 2026, 11:59 PM ET, as confirmed by official company announcements or credible news sources. The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange.
If the listed company undergoes a merger, this will only qualify for a “No” resolution if the transaction results in the listed company being fully absorbed, dissolved, or otherwise no longer capable of independently conducting an Initial Public Offering. Transactions in which the listed company continues as a parent or successor will not alone qualify for a “No” resolution.
This market will resolve early if the listed company completes an IPO by December 31, 2026, 11:59 PM ET.
The resolution source for this market is a consensus of credible reporting.Robust equity market performance and an active IPO pipeline are supporting trader sentiment on 2026 listings ahead of the December 31, 2026 resolution. Through late September, 122 IPOs have priced year-to-date, generating an average 8.5% return from issue price amid a Nasdaq Composite advance of 35%. Multiple sizable deals are slated to price imminently, including Oura’s $2.1 billion offering, Accelevation Holdings’ $660 million transaction, and ADARx Pharmaceuticals’ $350 million raise, while others such as Bamboo Insurance have been postponed. Favorable conditions reflect sustained risk appetite, with institutional demand for growth-oriented issuers in AI infrastructure, biotech, and consumer hardware. Key near-term catalysts include additional September and October pricings plus any confidential filings that could accelerate timelines for high-profile names.
This market will resolve to "Yes" if the listed company completes an Initial Public Offering (IPO) by December 31, 2026, 11:59 PM ET, as confirmed by official company announcements or credible news sources. The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange.
If the listed company merges with another entity, is acquired, or ceases to exist before the market resolves, the market will also resolve to "No".
This market will resolve early if the listed company completes an IPO by December 31, 2026, 11:59 PM ET.
The resolution source for this market is a consensus of credible reporting.
If the listed company merges with another entity, is acquired, or ceases to exist before the market resolves, the market will also resolve to "No".
This market will resolve early if the listed company completes an IPO by December 31, 2026, 11:59 PM ET.
The resolution source for this market is a consensus of credible reporting.
Market Opened: Feb 2, 2026, 3:25 PM ET
Volume
$7,377,936End Date
Jan 1, 2027Market Opened
Feb 2, 2026, 3:25 PM ETResolver
0x65070be91...Outcome proposed: Yes
No dispute
Final outcome: Yes
This market will resolve to "Yes" if the listed company completes an Initial Public Offering (IPO) by December 31, 2026, 11:59 PM ET, as confirmed by official company announcements or credible news sources. The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange.
If the listed company merges with another entity, is acquired, or ceases to exist before the market resolves, the market will also resolve to "No".
This market will resolve early if the listed company completes an IPO by December 31, 2026, 11:59 PM ET.
The resolution source for this market is a consensus of credible reporting.This market will resolve to "Yes" if the listed company completes an Initial Public Offering (IPO) by December 31, 2026, 11:59 PM ET, as confirmed by official company announcements or credible news sources. The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange.
If the listed company undergoes a merger, this will only qualify for a “No” resolution if the transaction results in the listed company being fully absorbed, dissolved, or otherwise no longer capable of independently conducting an Initial Public Offering. Transactions in which the listed company continues as a parent or successor will not alone qualify for a “No” resolution.
This market will resolve early if the listed company completes an IPO by December 31, 2026, 11:59 PM ET.
The resolution source for this market is a consensus of credible reporting.Robust equity market performance and an active IPO pipeline are supporting trader sentiment on 2026 listings ahead of the December 31, 2026 resolution. Through late September, 122 IPOs have priced year-to-date, generating an average 8.5% return from issue price amid a Nasdaq Composite advance of 35%. Multiple sizable deals are slated to price imminently, including Oura’s $2.1 billion offering, Accelevation Holdings’ $660 million transaction, and ADARx Pharmaceuticals’ $350 million raise, while others such as Bamboo Insurance have been postponed. Favorable conditions reflect sustained risk appetite, with institutional demand for growth-oriented issuers in AI infrastructure, biotech, and consumer hardware. Key near-term catalysts include additional September and October pricings plus any confidential filings that could accelerate timelines for high-profile names.
This market will resolve to "Yes" if the listed company completes an Initial Public Offering (IPO) by December 31, 2026, 11:59 PM ET, as confirmed by official company announcements or credible news sources. The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange.
If the listed company merges with another entity, is acquired, or ceases to exist before the market resolves, the market will also resolve to "No".
This market will resolve early if the listed company completes an IPO by December 31, 2026, 11:59 PM ET.
The resolution source for this market is a consensus of credible reporting.
If the listed company merges with another entity, is acquired, or ceases to exist before the market resolves, the market will also resolve to "No".
This market will resolve early if the listed company completes an IPO by December 31, 2026, 11:59 PM ET.
The resolution source for this market is a consensus of credible reporting.
Volume
$7,377,936End Date
Jan 1, 2027Market Opened
Feb 2, 2026, 3:25 PM ETResolver
0x65070be91...Outcome proposed: Yes
No dispute
Final outcome: Yes
Robust equity market performance and an active IPO pipeline are supporting trader sentiment on 2026 listings ahead of the December 31, 2026 resolution. Through late September, 122 IPOs have priced year-to-date, generating an average 8.5% return from issue price amid a Nasdaq Composite advance of 35%. Multiple sizable deals are slated to price imminently, including Oura’s $2.1 billion offering, Accelevation Holdings’ $660 million transaction, and ADARx Pharmaceuticals’ $350 million raise, while others such as Bamboo Insurance have been postponed. Favorable conditions reflect sustained risk appetite, with institutional demand for growth-oriented issuers in AI infrastructure, biotech, and consumer hardware. Key near-term catalysts include additional September and October pricings plus any confidential filings that could accelerate timelines for high-profile names.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions